Assay Development, Fragment Screening and Science

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Assay Development

Fragment Screening

Science

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

APRIL 7, 2025

PoLiPa technology Domainex’s Polymer Lipid Particle (PoLiPa) technology offers a versatile, detergent-free platform for the rapid, high-purity preparation of membrane proteins like GPCRs, ion channels and solute carriers, enabling assay development for these challenging targets. References Sun D, et al.

Fragment Screening

Fragment Screening Drugs Biophysical Assays Small Molecule

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. In terms of compound libraries, we have a high-throughput screening library of about 200,000 ligands. We can screen with many different formats and modalities.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Drug Discovery Digest

Advancements in hit identification for membrane protein drug discovery

Target-directed cancer: protein-ligand interactions

Stay Connected